Article Details
Retrieved on: 2025-03-20 17:22:37
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The company also highlighted Phase 1 proof-of-concept data from its DNA-encoded monoclonal antibody (DMAb) platform, which demonstrated sustained ...
Article found on: www.mychesco.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here